MedTrace Logo

Cohort of Tumors With POLE/D1 Mutation

NCT05103969 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-07-08

No results posted yet for this study

Summary

Primary objective of this study is to identify and describe the clinico-biological and molecular characteristics of tumors with somatic POLE (Polymerase ɛ)/POLD1 mutation identified by molecular biology platforms for all stages and primary sites combined

Conditions

  • Tumors
  • POLE Exonuclease Domain Mutation
  • POLD1 Gene Mutation

Sponsors & Collaborators

  • Federation Francophone de Cancerologie Digestive

    lead OTHER

Principal Investigators

  • Rosine GUIMBAUD, PhD.MD · Fédération francophone de Cancérologie digestive

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-05
Primary Completion
2025-10-06
Completion
2025-10-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05103969 on ClinicalTrials.gov